Meka Albert Frank Zeh, Billong Serge Clotaire, Diallo Ismael, Tiemtore Ousseni Wendlassida, Bongwong Brian, Nguefack-Tsague Georges
National Aids Control Committee, Ministry of Public Health, Yaounde, Cameroon.
Faculty of Medicine and Biomedical Sciences, University of Yaounde, Yaounde, Cameroon.
Pan Afr Med J. 2020 May 27;36:37. doi: 10.11604/pamj.2020.36.37.19046. eCollection 2020.
The year 2017 marked a transition period with the end of the implementation of Cameroon´s 2014-2017 HIV/AIDS National Strategic Plan (NSP) and the development of the 2018-2022 NSP. We assessed barriers and challenges to service delivery and uptake along the HIV care cascade in Cameroon to inform decision making within the framework of the new NSP, to achieve the UNAIDS 90-90-90 target.
We conducted a cross sectional descriptive study nationwide, enrolling HIV infected patients and staff. Data were collected on sociodemographic characteristics, HIV testing, antiretroviral therapy and viral load testing delivery and uptake and factors that limit their access.
A total of 137 staff and 642 people living with HIV (PLHIV) were interviewed. Of 642 PLHIV with known status, 339 (53%) repeated their HIV test at least once, with range: 1-10 and median: 2 (IQR: 1-3). Having attained secondary level of education (OR: 2.07, 95% CI: 1.04-4.14; P=0.04) or more (OR: 2.91, 95% CI: 1.16-7.28; P=0.02) were significantly associated with repeat testing. Psychological (refusal of service uptake and existence of HIV), community-level (stigmatization and fear of confidentiality breach) and commodity stock-outs "HIV test kits (21%), antiretrovirals (ARVs) (71.4%), viral load testing reagents (100%)" are the major barriers to service delivery and uptake along the cascade.
We identified individual, community-level, socio-economic and health care system related barriers which constitute persistent bottlenecks in HIV service delivery and uptake and a high rate of repeat testing by PLHIV with known status. Addressing all these accordingly can help the country achieve the UNAIDS 90-90-90 target.
2017年是一个过渡期,喀麦隆2014 - 2017年艾滋病毒/艾滋病国家战略计划(NSP)实施结束,同时开始制定2018 - 2022年NSP。我们评估了喀麦隆艾滋病毒治疗连续过程中服务提供和接受方面的障碍与挑战,以便在新的NSP框架内为决策提供信息,实现联合国艾滋病规划署的90 - 90 - 90目标。
我们在全国范围内开展了一项横断面描述性研究,纳入了艾滋病毒感染患者和工作人员。收集了关于社会人口学特征、艾滋病毒检测、抗逆转录病毒治疗、病毒载量检测的提供与接受情况以及限制其获取的因素的数据。
共采访了137名工作人员和642名艾滋病毒感染者(PLHIV)。在642名已知感染状况的PLHIV中,339名(53%)至少重复进行了一次艾滋病毒检测,检测次数范围为1 - 10次,中位数为2次(四分位间距:1 - 3)。接受过中等教育(比值比:2.07,95%置信区间:1.04 - 4.14;P = 0.04)或更高教育程度(比值比:2.91,95%置信区间:1.16 - 7.28;P = 0.02)与重复检测显著相关。心理层面(拒绝接受服务和存在对艾滋病毒的认知)、社区层面(污名化和担心保密性被破坏)以及商品缺货“艾滋病毒检测试剂盒(21%)、抗逆转录病毒药物(ARVs)(71.4%)、病毒载量检测试剂(100%)”是治疗连续过程中服务提供和接受的主要障碍。
我们确定了个体、社区层面、社会经济和医疗保健系统相关的障碍,这些障碍是艾滋病毒服务提供和接受方面持续存在的瓶颈,且已知感染状况的PLHIV重复检测率较高。相应地解决所有这些问题有助于该国实现联合国艾滋病规划署的90 - 90 - 90目标。